Hepatokines as a Link between Obesity and Cardiovascular Diseases
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yoo, Hye Jin | - |
dc.contributor.author | Choi, Kyung Mook | - |
dc.date.accessioned | 2021-09-04T19:29:15Z | - |
dc.date.available | 2021-09-04T19:29:15Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2015-02 | - |
dc.identifier.issn | 2233-6079 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/94454 | - |
dc.description.abstract | Non-alcoholic fatty liver disease, which is considered a hepatic manifestation of metabolic syndrome, independently increases the risks of developing cardiovascular disease (CVD) and type 2 diabetes mellitus. Recent emerging evidence suggests that a group of predominantly liver-derived proteins called hepatokines directly affect the progression of atherosclerosis by modulating endothelial dysfunction and infiltration of inflammatory cells into vessel walls. Here, we summarize the role of the representative hepatokines fibroblast growth factor 21, fetuin-A, and selenoprotein P in the progression of CVD. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN DIABETES ASSOC | - |
dc.subject | NONALCOHOLIC FATTY LIVER | - |
dc.subject | GROWTH-FACTOR 21 | - |
dc.subject | FETUIN-A LEVELS | - |
dc.subject | INSULIN-RESISTANCE | - |
dc.subject | SELENOPROTEIN-P | - |
dc.subject | DIABETES-MELLITUS | - |
dc.subject | RISK-FACTORS | - |
dc.subject | METABOLIC REGULATOR | - |
dc.subject | HEPATIC STEATOSIS | - |
dc.subject | ENDOTHELIAL-CELLS | - |
dc.title | Hepatokines as a Link between Obesity and Cardiovascular Diseases | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Yoo, Hye Jin | - |
dc.contributor.affiliatedAuthor | Choi, Kyung Mook | - |
dc.identifier.doi | 10.4093/dmj.2015.39.1.10 | - |
dc.identifier.scopusid | 2-s2.0-84923239473 | - |
dc.identifier.wosid | 000368000300002 | - |
dc.identifier.bibliographicCitation | DIABETES & METABOLISM JOURNAL, v.39, no.1, pp.10 - 15 | - |
dc.relation.isPartOf | DIABETES & METABOLISM JOURNAL | - |
dc.citation.title | DIABETES & METABOLISM JOURNAL | - |
dc.citation.volume | 39 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 10 | - |
dc.citation.endPage | 15 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART001962037 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Endocrinology & Metabolism | - |
dc.relation.journalWebOfScienceCategory | Endocrinology & Metabolism | - |
dc.subject.keywordPlus | NONALCOHOLIC FATTY LIVER | - |
dc.subject.keywordPlus | GROWTH-FACTOR 21 | - |
dc.subject.keywordPlus | FETUIN-A LEVELS | - |
dc.subject.keywordPlus | INSULIN-RESISTANCE | - |
dc.subject.keywordPlus | SELENOPROTEIN-P | - |
dc.subject.keywordPlus | DIABETES-MELLITUS | - |
dc.subject.keywordPlus | RISK-FACTORS | - |
dc.subject.keywordPlus | METABOLIC REGULATOR | - |
dc.subject.keywordPlus | HEPATIC STEATOSIS | - |
dc.subject.keywordPlus | ENDOTHELIAL-CELLS | - |
dc.subject.keywordAuthor | Fetuin-A | - |
dc.subject.keywordAuthor | Fibroblast growth factor 21 | - |
dc.subject.keywordAuthor | Hepatokines | - |
dc.subject.keywordAuthor | Non-alcoholic fatty liver disease | - |
dc.subject.keywordAuthor | Selenoprotein P | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.